Annual Meeting Lunch and Learn

0414-annual-meeting-on-Womens-cancer

Annual Meeting > SGO Lunch and Learn

SGO Lunch and Learn

Monday, March 13, 2017
12:00 p.m. – 1:30 p.m.
Maryland Ballroom A/C

Mechanisms of Action: Clinical Management of New Biologics and Immunotherapies in Gynecologic Oncology

Registration

Register for the Lunch and Learn through SGO’s online system. Please note this is a separate site from the Annual Meeting registration website.

Course Directors

  • Linda Duska, MD, University of Virginia Health System, Charlottesville, VA
  • Elise Kohn, MD, CTEP/DCTD,  National Cancer Institute, Rockville, MD

Faculty

  • John L. Hays, MD, PhD, Medical Oncologist, The Ohio State University, Columbus, OH
  • Kunle O. Odunsi, MD, PhD, Professor and Chair, Roswell Park Cancer Institute, Buffalo, NY
  • Angeles Alvarez-Secord, MD, Professor, Duke University Medical Center, Durham, NC

Description

Targeted therapies are at the center of major advancements in the treatment of women’s cancer, but many aspects of this treatment are not yet well enough understood by gynecologic oncologists.

This course will:

  • Address which new biologics are appropriate for which patients and why.
  • Investigate tumor sequencing in order to best understand each patient’s ideal treatment plan.
  • Delineate appropriate dosing for optimal patient outcomes and minimal toxicities while addressing plans of action to combat side effects.

Topics

  • Targeted agents in gynecologic cancer: ready for prime time or the graveyard slot? John L. Hays, MD
  • Immunotherapy in ovarian cancer: what is the evidence really? (Cautiously optimistic or recklessly pessimistic?) Kunle O. Odunsi, MD
  • Understanding Toxicities of Targeted Agents: Implications for Anti-tumor Activity and Management, Angeles Alvarez-Secord, MD
  • Current status and future promise, Linda Duska, MD, and Elise Kohn, MD

This session is intended for all Annual Meeting attendees.

As a Lunch and Learn session within the 2017 SGO Annual Meeting on Women’s Cancer, this course is included in the CME granted by SGO. SGO is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This activity is supported by AstraZeneca and TESARO. CME is awarded by SGO.